子供用インフルエンザワクチンのグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Children Influenza Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16103 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

子供用インフルエンザワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の子供用インフルエンザワクチンの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の子供用インフルエンザワクチンの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 子供用インフルエンザワクチン市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・点鼻薬、注射 用途別セグメントは次のように区分されます。 ・6か月～3歳、3歳以上 世界の子供用インフルエンザワクチン市場の主要な市場プレーヤーは以下のとおりです。 ・Sanofi Pasteur、CSL、GSK、Mylan、Hulan Bio、AstraZeneca、CCBIO 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、子供用インフルエンザワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な子供用インフルエンザワクチンメーカーの企業概要、2019年～2021年までの子供用インフルエンザワクチンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な子供用インフルエンザワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別子供用インフルエンザワクチンの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの子供用インフルエンザワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での子供用インフルエンザワクチン市場予測を収録しています。 ・第12、13、14章では、子供用インフルエンザワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Sanofi Pasteur、CSL、GSK、Mylan、Hulan Bio、AstraZeneca、CCBIO ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：点鼻薬、注射 ・用途別分析2016年-2026年：6か月～3歳、3歳以上 ・子供用インフルエンザワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・子供用インフルエンザワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・子供用インフルエンザワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・子供用インフルエンザワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・子供用インフルエンザワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Children Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Children Influenza Vaccine size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Children Influenza Vaccine market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Children Influenza Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Nasal Spray
Injection

Market segment by Application can be divided into
6 Months to 3 Years
Over 3 Years

The key market players for global Children Influenza Vaccine market are listed below:
Sanofi Pasteur
CSL
GSK
Mylan
Hulan Bio
AstraZeneca
CCBIO

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Children Influenza Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Children Influenza Vaccine, with price, sales, revenue and global market share of Children Influenza Vaccine from 2019 to 2021.
Chapter 3, the Children Influenza Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Children Influenza Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Children Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Children Influenza Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Children Influenza Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Children Influenza Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Nasal Spray
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Children Influenza Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 6 Months to 3 Years
1.3.3 Over 3 Years
1.4 Global Children Influenza Vaccine Market Size & Forecast
1.4.1 Global Children Influenza Vaccine Sales in Value (2016-2026))
1.4.2 Global Children Influenza Vaccine Sales in Volume (2016-2026)
1.4.3 Global Children Influenza Vaccine Price by Type (2016-2026) & (US$/Unit)
1.5 Global Children Influenza Vaccine Production Capacity Analysis
1.5.1 Global Children Influenza Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Children Influenza Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Children Influenza Vaccine Market Drivers
1.6.2 Children Influenza Vaccine Market Restraints
1.6.3 Children Influenza Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Children Influenza Vaccine Product and Services
2.1.4 Sanofi Pasteur Children Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Children Influenza Vaccine Product and Services
2.2.4 CSL Children Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Children Influenza Vaccine Product and Services
2.3.4 GSK Children Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Children Influenza Vaccine Product and Services
2.4.4 Mylan Children Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Hulan Bio
2.5.1 Hulan Bio Details
2.5.2 Hulan Bio Major Business
2.5.3 Hulan Bio Children Influenza Vaccine Product and Services
2.5.4 Hulan Bio Children Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Children Influenza Vaccine Product and Services
2.6.4 AstraZeneca Children Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 CCBIO
2.7.1 CCBIO Details
2.7.2 CCBIO Major Business
2.7.3 CCBIO Children Influenza Vaccine Product and Services
2.7.4 CCBIO Children Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Children Influenza Vaccine Sales by Manufacturer
3.1 Global Children Influenza Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Children Influenza Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Children Influenza Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Children Influenza Vaccine Manufacturer Market Share
3.4.2 Top 6 Children Influenza Vaccine Manufacturer Market Share
3.5 Global Children Influenza Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Children Influenza Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Children Influenza Vaccine Market Size by Region
4.1.1 Global Children Influenza Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Children Influenza Vaccine Revenue by Region (2016-2026)
4.2 North America Children Influenza Vaccine Revenue (2016-2026)
4.3 Europe Children Influenza Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Children Influenza Vaccine Revenue (2016-2026)
4.5 South America Children Influenza Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Children Influenza Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Children Influenza Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Children Influenza Vaccine Revenue by Type (2016-2026)
5.3 Global Children Influenza Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Children Influenza Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Children Influenza Vaccine Revenue by Application (2016-2026)
6.3 Global Children Influenza Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Children Influenza Vaccine Sales by Type (2016-2026)
7.2 North America Children Influenza Vaccine Sales by Application (2016-2026)
7.3 North America Children Influenza Vaccine Market Size by Country
7.3.1 North America Children Influenza Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Children Influenza Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Children Influenza Vaccine Sales by Type (2016-2026)
8.2 Europe Children Influenza Vaccine Sales by Application (2016-2026)
8.3 Europe Children Influenza Vaccine Market Size by Country
8.3.1 Europe Children Influenza Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Children Influenza Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Children Influenza Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Children Influenza Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Children Influenza Vaccine Market Size by Region
9.3.1 Asia-Pacific Children Influenza Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Children Influenza Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Children Influenza Vaccine Sales by Type (2016-2026)
10.2 South America Children Influenza Vaccine Sales by Application (2016-2026)
10.3 South America Children Influenza Vaccine Market Size by Country
10.3.1 South America Children Influenza Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Children Influenza Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Children Influenza Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Children Influenza Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Children Influenza Vaccine Market Size by Country
11.3.1 Middle East & Africa Children Influenza Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Children Influenza Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Children Influenza Vaccine Typical Distributors
12.3 Children Influenza Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Children Influenza Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Children Influenza Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Children Influenza Vaccine Product and Services
Table 6. Sanofi Pasteur Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. CSL Basic Information, Manufacturing Base and Competitors
Table 8. CSL Major Business
Table 9. CSL Children Influenza Vaccine Product and Services
Table 10. CSL Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GSK Basic Information, Manufacturing Base and Competitors
Table 12. GSK Major Business
Table 13. GSK Children Influenza Vaccine Product and Services
Table 14. GSK Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Mylan Basic Information, Manufacturing Base and Competitors
Table 16. Mylan Major Business
Table 17. Mylan Children Influenza Vaccine Product and Services
Table 18. Mylan Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Hulan Bio Basic Information, Manufacturing Base and Competitors
Table 20. Hulan Bio Major Business
Table 21. Hulan Bio Children Influenza Vaccine Product and Services
Table 22. Hulan Bio Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Children Influenza Vaccine Product and Services
Table 26. AstraZeneca Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. CCBIO Basic Information, Manufacturing Base and Competitors
Table 28. CCBIO Major Business
Table 29. CCBIO Children Influenza Vaccine Product and Services
Table 30. CCBIO Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Children Influenza Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
Table 32. Global Children Influenza Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Children Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Children Influenza Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Children Influenza Vaccine Production Site of Key Manufacturer
Table 36. Children Influenza Vaccine New Entrant and Capacity Expansion Plans
Table 37. Children Influenza Vaccine Mergers & Acquisitions in the Past Five Years
Table 38. Global Children Influenza Vaccine Sales by Region (2016-2021e) & (K Units)
Table 39. Global Children Influenza Vaccine Sales by Region (2021-2026) & (K Units)
Table 40. Global Children Influenza Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global Children Influenza Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 42. Global Children Influenza Vaccine Sales by Type (2016-2021e) & (K Units)
Table 43. Global Children Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 44. Global Children Influenza Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global Children Influenza Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 46. Global Children Influenza Vaccine Price by Type (2016-2021e) & (US$/Unit)
Table 47. Global Children Influenza Vaccine Price by Type (2021-2026) & (US$/Unit)
Table 48. Global Children Influenza Vaccine Sales by Application (2016-2021e) & (K Units)
Table 49. Global Children Influenza Vaccine Sales by Application (2021-2026) & (K Units)
Table 50. Global Children Influenza Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global Children Influenza Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 52. Global Children Influenza Vaccine Price by Application (2016-2021e) & (US$/Unit)
Table 53. Global Children Influenza Vaccine Price by Application (2021-2026) & (US$/Unit)
Table 54. North America Children Influenza Vaccine Sales by Country (2016-2021e) & (K Units)
Table 55. North America Children Influenza Vaccine Sales by Country (2021-2026) & (K Units)
Table 56. North America Children Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America Children Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 58. North America Children Influenza Vaccine Sales by Type (2016-2021e) & (K Units)
Table 59. North America Children Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 60. North America Children Influenza Vaccine Sales by Application (2016-2021e) & (K Units)
Table 61. North America Children Influenza Vaccine Sales by Application (2021-2026) & (K Units)
Table 62. Europe Children Influenza Vaccine Sales by Country (2016-2021e) & (K Units)
Table 63. Europe Children Influenza Vaccine Sales by Country (2021-2026) & (K Units)
Table 64. Europe Children Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe Children Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe Children Influenza Vaccine Sales by Type (2016-2021e) & (K Units)
Table 67. Europe Children Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 68. Europe Children Influenza Vaccine Sales by Application (2016-2021e) & (K Units)
Table 69. Europe Children Influenza Vaccine Sales by Application (2021-2026) & (K Units)
Table 70. Asia-Pacific Children Influenza Vaccine Sales by Region (2016-2021e) & (K Units)
Table 71. Asia-Pacific Children Influenza Vaccine Sales by Region (2021-2026) & (K Units)
Table 72. Asia-Pacific Children Influenza Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific Children Influenza Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific Children Influenza Vaccine Sales by Type (2016-2021e) & (K Units)
Table 75. Asia-Pacific Children Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 76. Asia-Pacific Children Influenza Vaccine Sales by Application (2016-2021e) & (K Units)
Table 77. Asia-Pacific Children Influenza Vaccine Sales by Application (2021-2026) & (K Units)
Table 78. South America Children Influenza Vaccine Sales by Country (2016-2021e) & (K Units)
Table 79. South America Children Influenza Vaccine Sales by Country (2021-2026) & (K Units)
Table 80. South America Children Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America Children Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 82. South America Children Influenza Vaccine Sales by Type (2016-2021e) & (K Units)
Table 83. South America Children Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 84. South America Children Influenza Vaccine Sales by Application (2016-2021e) & (K Units)
Table 85. South America Children Influenza Vaccine Sales by Application (2021-2026) & (K Units)
Table 86. Middle East & Africa Children Influenza Vaccine Sales by Country (2016-2021e) & (K Units)
Table 87. Middle East & Africa Children Influenza Vaccine Sales by Country (2021-2026) & (K Units)
Table 88. Middle East & Africa Children Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa Children Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa Children Influenza Vaccine Sales by Type (2016-2021e) & (K Units)
Table 91. Middle East & Africa Children Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 92. Middle East & Africa Children Influenza Vaccine Sales by Application (2016-2021e) & (K Units)
Table 93. Middle East & Africa Children Influenza Vaccine Sales by Application (2021-2026) & (K Units)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. Children Influenza Vaccine Typical Distributors
Table 97. Children Influenza Vaccine Typical Customers
List of Figures
Figure 1. Children Influenza Vaccine Picture
Figure 2. Global Children Influenza Vaccine Sales Market Share by Type in 2020
Figure 3. Nasal Spray
Figure 4. Injection
Figure 5. Global Children Influenza Vaccine Sales Market Share by Application in 2020
Figure 6. 6 Months to 3 Years
Figure 7. Over 3 Years
Figure 8. Global Children Influenza Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Children Influenza Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Children Influenza Vaccine Sales (2016-2026) & (K Units)
Figure 11. Global Children Influenza Vaccine Price by Type (2016-2026) & (US$/Unit)
Figure 12. Global Children Influenza Vaccine Production Capacity (2016-2026) & (K Units)
Figure 13. Global Children Influenza Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Children Influenza Vaccine Market Drivers
Figure 15. Children Influenza Vaccine Market Restraints
Figure 16. Children Influenza Vaccine Market Trends
Figure 17. Global Children Influenza Vaccine Sales Market Share by Manufacturer in 2020
Figure 18. Global Children Influenza Vaccine Revenue Market Share by Manufacturer in 2020
Figure 19. Children Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Children Influenza Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Children Influenza Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Children Influenza Vaccine Sales Market Share by Region (2016-2026)
Figure 23. Global Children Influenza Vaccine Revenue Market Share by Region (2016-2026)
Figure 24. North America Children Influenza Vaccine Revenue (2016-2026) & (USD Million)
Figure 25. Europe Children Influenza Vaccine Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Children Influenza Vaccine Revenue (2016-2026) & (USD Million)
Figure 27. South America Children Influenza Vaccine Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Children Influenza Vaccine Revenue (2016-2026) & (USD Million)
Figure 29. Global Children Influenza Vaccine Sales Market Share by Type (2016-2026)
Figure 30. Global Children Influenza Vaccine Revenue Market Share by Type (2016-2026)
Figure 31. Global Children Influenza Vaccine Price by Type (2016-2026) & (US$/Unit)
Figure 32. Global Children Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 33. Global Children Influenza Vaccine Revenue Market Share by Application (2016-2026)
Figure 34. Global Children Influenza Vaccine Price by Application (2016-2026) & (US$/Unit)
Figure 35. North America Children Influenza Vaccine Sales Market Share by Type (2016-2026)
Figure 36. North America Children Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 37. North America Children Influenza Vaccine Sales Market Share by Country (2016-2026)
Figure 38. North America Children Influenza Vaccine Revenue Market Share by Country (2016-2026)
Figure 39. United States Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Children Influenza Vaccine Sales Market Share by Type (2016-2026)
Figure 43. Europe Children Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 44. Europe Children Influenza Vaccine Sales Market Share by Country (2016-2026)
Figure 45. Europe Children Influenza Vaccine Revenue Market Share by Country (2016-2026)
Figure 46. Germany Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Children Influenza Vaccine Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Children Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Children Influenza Vaccine Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Children Influenza Vaccine Revenue Market Share by Region (2016-2026)
Figure 55. China Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Children Influenza Vaccine Sales Market Share by Type (2016-2026)
Figure 62. South America Children Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 63. South America Children Influenza Vaccine Sales Market Share by Country (2016-2026)
Figure 64. South America Children Influenza Vaccine Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Children Influenza Vaccine Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Children Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Children Influenza Vaccine Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Children Influenza Vaccine Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Children Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source

---